XML 82 R69.htm IDEA: XBRL DOCUMENT v3.19.2
Subsequent Event (Details) - Subsequent Event - Collaboration Agreement with Aurigene Discovery Technologies Limited Collaboration Agreement
$ in Millions
1 Months Ended
Jul. 31, 2019
USD ($)
program
Subsequent Event [Line Items]  
Number of oncology programs included in collaboration agreement | program 6
Upfront payment $ 10.0
Additional upfront payment 2.5
Research funding commitment (up to) 32.6
Maximum amount eligible for development and regulatory milestones 148.8
Maximum amount eligible for commercial milestones under collaborations agreement 280.0
Minimum  
Subsequent Event [Line Items]  
Option exercise fee payment, if exercised 10.0
Maximum  
Subsequent Event [Line Items]  
Option exercise fee payment, if exercised $ 12.0